CD45+ lymphocyte populations were significantly reduced (at termination) in the tumors of LL/2 tumor bearing mice treated with PEG-mIL12 compared with PEG-lucia and vehicle controls, but there was no significant difference in the levels of CD4+CD8− or CD8+CD4− cells between the three groups (Fig. S7). The gene discussed is CD4; the disease is neoplasm.